Immudyne Announces Definitive Endorsement Agreement with Leading Dermatologist
December 07 2016 - 8:30AM
ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader
in the development and marketing of OTC health and wellness
products addressing large unmet needs, today announced
that a Definitive Agreement has been reached with Dr.
Lilliana Ramirez to endorse and assist with the development of a
new line of skincare products based on Immudyne’s proprietary Yeast
Beta Glucan ingredient. The brand, Inate MD, will be launched
nationally January 1, 2017.
Dr. Lilliana Ramirez is a practicing, board certified
dermatologist with a distinguished track record in medicine and
academics. She graduated Magna Cum Laude from the University
of Puerto Rico and has received many awards for both her research
and the practice of medicine.
“Immudyne is partnering with and associating our brand with yet
another highly accomplished dermatologist,” stated Mark McLaughlin,
President and CEO of Immudyne.
“I’m very pleased to be working with Immudyne,” said
Dr. Ramirez. "The Inate MD skincare line is backed by
excellent science and a great management team. I think my
patients and consumers across the county will enjoy and benefit
from use of the Inate MD product line.”
The Inate MD line will initially be available exclusively online
and will consist of a Serum, Moisturizer, Instant Wrinkle Eraser
and an optional nutritional supplement to support healthier skin
and the human Immune System.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Reliance should not be placed on forward-looking
statements because they involve unknown risks, uncertainties and
other factors, which are, in some cases, beyond the control of
Immudyne. Actual events, performance or results could differ
materially from the anticipated events, performance or results
expressed or implied by such forward-looking statements. We
undertake no obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events or otherwise.
About ImmuDyne, Inc.
lmmuDyne, Inc. (the "Company") is a health and wellness company
which develops, manufactures, markets, and sells innovative
lifestyle products. The Company's lead products contain its
proprietary yeast beta glucans that have been shown through testing
and analysis to support the immune system. ImmuDyne also has a
majority owned direct marketing division that markets immune
support, skincare and hair loss products directly to consumers
around the world. All of the Company’s intellectual property is
protected by patents and/or trade secrets. Additional information
can be found on the web at www.immudyne.com.
Contact:
lmmuDyne, Inc.
Mark McLaughlin: +1-914-714-8901